Particularly, an increased susceptibility for Candida infections in critically ill COVID-19 patients was suggested by the observation of impaired immune response to those pathogens characterized by the abrogated release of IL-6, TNF, IL-1α, and IL-1β toward Candida albicans [35]. The gene discussed is IL1A; the disease is COVID-19.